Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-03-06

Clinical Trial Update: Effects of Caffeinated and Decaffeinated Coffee on Body Weight and Glucose Tolerance [NA]

View source ↗

Summary

A National Institute of Diabetes and Digestive and Kidney Diseases trial comparing caffeinated and decaffeinated coffee on body weight and glucose tolerance in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Overweight | NA | Status: COMPLETED